Interaction Checker

Add peptides or compounds to check all pairwise interactions, cumulative organ load, and safety flags.

This stack requires monitoring: 0 interaction(s) need attention. No critical conflicts, but bloodwork and regular check-ins recommended.
Elevated gonads load from Anastrozole, Trenbolone. Monitor this organ system closely.

Cumulative Organ Load

Gonads
elevated
Heart
moderate
Liver
moderate
Pituitary
low

Shared Safety Flags

2x 2 androgenic compounds (Anastrozole, Trenbolone). Additive androgenic load — increased risk of hair loss, acne, prostate effects.
2x 2 estrogenic compounds (Anastrozole, Trenbolone). Combined estrogen elevation — monitor E2 and consider aromatase inhibitor.
2x 2 hepatotoxic compounds (Anastrozole, Trenbolone). Liver damage risk significantly increased. Include liver support (TUDCA/NAC) and monitor ALT/AST.
2x 2 HPTA-suppressive compounds (Anastrozole, Trenbolone). Deep hormonal shutdown expected — plan extended PCT.
2x 2 compounds disrupt lipids (Anastrozole, Trenbolone). Get lipid panel mid-cycle — consider adding lipid support.
2x 2 compounds share the teratogenic safety flag (Anastrozole, Trenbolone). Monitor accordingly.
+
Anastrozole + Trenbolone
Compatible

Aromatase inhibitors are typically unnecessary for managing trenbolone directly, since trenbolone does not aromatize to estrogen. However, the concurrent testosterone base will aromatize, and AI use may be needed to manage estradiol from that source. Importantly, estrogen management becomes more nuanced with trenbolone because progesterone receptor activation can sensitize breast tissue to even normal estradiol levels, potentially requiring lower estradiol targets than usual.

Researched 90% confidence Compare

Interaction data is compiled from research literature, pharmacological analysis, and community reports. Inferred interactions are based on known mechanisms and may not reflect all real-world outcomes. Always consult a healthcare professional before combining compounds.